Navigation

TA207 Mantle cell lymphoma (relapsed) - temsirolimus (terminated appraisal): advice

The published full guidance on temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma.

It presents NICE's advice to the NHS on the use of this treatment.

This page was last updated: 22 October 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.